Abstract Background: Depth of invasion (DOI) in oral cavity cancer is important in determining prognosis. This study aims to determine optimal cut-points of DOI for detection of occult disease and survival. Methods: A retrospective cohort study was completed of previously untreated early stage lateral oral tongue cancer. DOI cut-points were computed. Multiple logistic regression and multivariate Cox proportional hazards models were used to assess predictors of occult nodal disease and overall survival (OS) and diseasespecific survival (DSS). Results: Occult nodal disease was found in 55 (26%) of the 212 patients. DOI of 7.25 mm was most predictive for occult nodal disease and 8 mm for OS and DSS. DOI was an independent predictor of OS and DSS. Conclusion: The optimal DOI cut-point for detection of occult nodal metastasis was 7.25 and 8 mm for OS and DSS at 5 years. DOI is an independent predictor of OS and DSS.
| INTRODUCTION
Oral tongue cancer is expected to affect approximately 17 110 individuals in the United States, resulting in 2510 deaths in 2018. 1 Oral tongue squamous cell carcinoma (OTSCC) is the most common type of oral tongue cancer. Initial presentation with nodal disease is a clear indicator for therapeutic neck dissection. Currently, recommendation of elective neck dissection is based on the depth of invasion (DOI) of the primary tumor. 2 A cut-point of 4 mm has been traditionally used to guide the decision for elective neck dissection based on a study by Kligerman et al. 2, 3 Subsequent studies have demonstrated a large range of optimal cutpoints for detection of occult disease, improving survival, and decreasing risk of recurrent disease. [4] [5] [6] [7] [8] [9] [10] Despite these studies investigating DOI in oral cavity disease, multiple issues make interpretation of the results difficult. Most prominently, the definition of DOI is not standardized and the term is often used interchangeably with tumor thickness. 4, 7 Additionally, cut-points are often decided a priori, sometimes based on historical studies, rather than optimization of sensitivity and specificity. Lastly, oral cavity subsites were often analyzed together, possibly introducing confounding due differences in prognosis by tumor site.
study utilizes a large, homogenous cohort of patients with lateral OTSCC, standardized pathologic measurement of DOI, and analysis of DOI as a continuous variable to define optimal DOI cut-points for detection of occult nodal disease and survival.
| PATIENTS AND METHODS
Following institutional review board approval, a retrospective cohort study was completed for all patients with lateral OTSCC treated at the MD Anderson Cancer Center between March 1997 and March 2012. Data collection were completed in October 2017 and were analyzed in January 2018.
Patients had tumors ≤4 cm and were undergoing elective neck dissection at the time of surgical extirpation of the tumor. Patients seen with recurrent disease, regional or distant metastatic disease, missing staging data, follow-up less than 1 month, or pathology unavailable for re-review were excluded from the cohort. DOI was defined as according to the eighth edition of the AJCC staging manual.
12 DOI was measured using the basement membrane of the adjacent normal epithelium, creating a line perpendicular to this horizontal, and measuring to the deepest point of tumor invasion in millimeters. To ensure consistency in measurement, DOI was reassessed in all pathologic specimens by a head and neck specific pathologist (D.B.) blinded to patient clinical information and outcome. The primary outcome measures were the presence of occult nodal disease, overall survival (OS), and diseasespecific survival (DSS). The presence of occult nodal disease was defined as pathological evidence of regional metastasis of OTSCC. OS was defined as the months elapsed between time of diagnosis and death or lost to follow-up, whichever came first. DSS was measured as months between diagnosis and death due to OTSCC. Disease covariates included demographic (age and sex), staging, and pathological (tumor size, presence of perineural invasion, lymphovascular invasion, margin status, differentiation) characteristics. Treatment characteristics, including the extent of neck dissection and the use of adjuvant therapy, were collected.
| Statistical analysis
Descriptive statistics were calculated for all baseline characteristics. Due to the right skewed distribution of DOI, a square root transformation (srDOI) was completed to better approximate a normal distribution. A logistic regression model was used to compute a receiver operating characteristic (ROC) function for the odds of occult disease according to DOI. Time-dependent ROC functions were used to determine the sensitivity and specificity of DOI on OS and DSS. 13 Youden indices were used to establish optimal DOI cut-points. Univariate and multivariate logistic regression and Cox proportional hazards models were used to identify predictors of occult nodal disease, OS, and DSS. 3 | RESULTS
| Study cohort
Three-hundred five patients were reviewed for inclusion. Forty-five patients were excluded due to not receiving neck dissection. These patients had a median DOI of 2 mm (range = 1-25 mm) and were statistically significantly thinner than those undergoing neck dissection (effect size = −0.49, 95% confidence interval [CI] = −0.71 to 0.07). For other reasons for exclusions, see Supporting Information Supplemental Figure 1 . A total of 212 patients were included in the final analysis. Baseline characteristics are summarized in Table 1 . Clinically, 81 patients (38%) were classified as T1 tumors and 131 patients (62%) T2 tumors. Median DOI was 7 mm (range = 1-25 mm). Two patients (1%) underwent bilateral neck dissection, and the remaining 210 patients (99%) underwent unilateral dissection only. One hundred ninety-five patients (92%) underwent selective neck dissection and 17 patients (8%) modified radical neck dissection. Neck dissection yielded a median of 27 lymph nodes (range = 5-90).
| DOI as a predictor of occult nodal disease
Following elective neck dissection, 55 patients (26%) had pathologic evidence of nodal disease. The odds of occult nodal disease increased by 1.89 times per unit increase of srDOI (95% CI = 1.23-2.91; Table 2 ). After adjustment for T classification, perineural invasion, lymphovascular invasion, and tumor differentiation, the odds of occult disease increased by 1.29 times per unit increase of srDOI (95% = 0.76-2.21; Table 2 ).
Using the logistic regression model, an ROC was calculated with an area under the curve (AUC) of 0.721 
| DOI as a predictor of OS
Five-year OS for the entire cohort was 77.8%. In those without occult nodal disease, 5-year OS was 82.1% (95% CI = 74.9%-87.5%) compared to 65.0% (95% CI = 50.8%-76.1%) in those with occult nodal disease (P < .001; Figure 1A ). Univariate Cox proportional hazards model found that the hazard of death increased by 1.81 per unit increase of srDOI (95% CI = 1.32-2.49). Other associations with OS include age, T classification, N classification, perineural invasion, lymphovascular invasion, margin status, and tumor differentiation (Supporting Information Supplemental Table 2 ). Following multivariate adjustment with age, N classification, perineural invasion, differentiation, and receipt of adjuvant radiotherapy, hazard of death increased by 1.48 times per unit increase in srDOI (95% CI = 1.03-2.12). Other independent predictors of OS were N classification (N1: HR = 2.07; 95% CI = 1.12-3.81; N2: HR = 2.61, 95% CI = 1.09-6.28), and poorly differentiated tumors (HR = 3.56, 95% CI = 1.51-8.36; Table 3 ).
Time-dependent ROC analysis demonstrated that 8 mm was an optimal cut-point for OS, with an AUC of 0.598 (Supporting Information Supplemental Figure 2b ). At this cut-point, the positive likelihood ratio was 1.46. The proportion of patients with occult nodal disease with tumors thinner than 8 mm was 19.7% (Supporting Information Supplemental Table 1 ). Patients with lesions DOI <8 mm had a 5-year OS of 83.4% (95% CI = 84.3%-94.6%) and 67.2% (95% CI = 55.1%-76.7%) in those with DOI ≥8 mm (P = .003; Figure 2A ). As a categorical variable, the AIC for the multivariate model using the 8-mm cut-point was lower (AIC = 628.52) compared to 4 mm (AIC = 632.80) and 5 mm (AIC = 633.76) cut-points.
| DOI as a predictor of DSS
Five-year DSS for the entire cohort was 87.7%. In those without occult neck disease, 5-year DSS was 90.9% (95% CI = 84.7%-94.6%) and 79.2% (95% CI = 65.5%-87.9%) in those with occult disease (P = .02; Figure 1B ). On univariate analysis, the hazard of disease-specific death increases 2.42 times per unit increase of srDOI (95% CI = 1.44-4.06). T classification, N2 nodal disease, perineural invasion, poorly differentiated tumors, and receipt of adjuvant radiotherapy were also associated with poorer DSS (Supporting Information Supplemental Table 2 ). After adjusting for age and differentiation of the tumor, hazard of disease-specific death increases by 2.25 times per unit increase in srDOI (95% CI = 1.28-3.95). Poorly differentiated tumors were another independent predictor of DSS (HR = 3.56, 95% CI = 1.18-12.21; Table 3 ).
Time-dependent ROC analysis demonstrated that 8 mm was an optimal cut-point for DSS, with an AUC of 0.650 (Supporting Information Supplemental Figure 2c ). At this cut-point, the positive likelihood ratio was 1.74. Patients with lesions DOI <8 mm had a 5-year DSS of 93.3% (95% CI = 87.0%-96.6%) and 77.8% (95% CI = 66.3%-85.8%) in those with DOI ≥8 mm (P < .001; Figure 2B ). With DOI as a categorical variable, the AIC of the multivariate model was at its minimum with a cut-point of 8 mm (AIC = 252.56) compared to 4 mm (AIC = 254.87) and 5 mm (AIC = 257.93) cut-points. 
| Adjuvant radiotherapy
A total of 65 patients (31%) underwent adjuvant radiotherapy. In patients with occult nodal disease, 38 patients (69%) underwent radiotherapy compared to 27 (17%) in those without occult nodal disease (P < .001 respectively. There were no differences in OS or DSS in patients without (P = .19, P = .61, respectively) or with (P = .38, P = .32, respectively) occult nodal disease.
| Recurrent disease
A total of 17 patients (8%) had local recurrence only, 13 (6%) had regional recurrence only, and 11 (5%) had both regional and local recurrence. srDOI was not associated with regional recurrence (OR = 1.03, 95% CI = 0.58-1.83) nor local recurrence (OR = 1.30, 95% CI = 0.77-2.22). In patients having regional recurrence, recurrence in the ipsilateral level 1B was most common (6 patients, 25%) followed by 5 patients (21%) having recurrent disease in the ipsilateral level 2A and contralateral levels 1B and 2A. Due to the low number of events, DOI cut-point analysis was unable to be performed (AUC = 0.522).
| DISCUSSION
This study focused on a highly specific patient cohort with lateral OTSCC measuring ≤4 cm. Measurement of DOI was standardized according to the definition in the eighth edition FIGURE 2 Kaplan-Meier survival curve of (A) overall survival and (B) disease-specific survival for patients with early stage lateral oral tongue squamous cell carcinoma using an 8-mm cut-point identified using receiver operating characteristic curve analysis [Color figure can be viewed at wileyonlinelibrary.com] of the AJCC. 12 Variability in the reporting of DOI was minimized by using a single, blinded, head and neck specialized pathologist. Although we confirmed that DOI was an independent predictor of OS and DSS, it was not found to be associated with detection of occult nodal disease after multivariate adjustment. In this highly uniform and specialized cohort, we demonstrated that the optimal cut-point for detection of occult nodal disease was 7.25 and 8 mm for OS and DSS, respectively, in contrast to the traditional cut-point of 4 mm first described by Kligerman et al. 3 This study attempted to control for possible confounding of the differing prognosis in oral cavity subsites by restricting the study population to patients with lateral OTSCC. There have been multiple previous attempts to characterize the effect of tumor thickness and DOI on patient prognosis in OTSCC. 5, 6, 8, 9, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] However, tumor thickness and DOI were often used interchangeably, and most studies investigated tumor thickness rather than DOI. In other studies, description of the measurement technique was lacking, making interpretation difficult. Cut-points found ranged widely, from 2 to 10 mm. However, many of these cut-points were decided a priori, based on historical studies rather than the findings of the study, and none investigated DOI as a continuous variable. In an attempt to synthesize all data, Pentenero et al. 4 performed a systematic review of the literature. However, due to the heterogeneity of pathologic measurement technique and inclusion criteria, meta-analysis was unable to be completed. There exists more data when all oral cavity subsites are considered. However, few studies have investigated DOI as a continuous variable. Liao et al. 30 measured hazard ratios for OS according to 1 mm increments in tumor depth, finding cut-points of 10-12 mm were most discriminant. However, the method of measurement of tumor depth was not described so it is difficult to interpret the significance of these values. Ebrahimi et al. 31 published a study investigating DOI as a continuous variable and found an optimal cutpoint of 5 mm in T1 tumors and 10 mm in T2-4 tumors based on DSS. As this was a multicenter trial, it was unable to use a uniform definition of DOI, and some centers measured tumor thickness rather than DOI. Although the potential effect of these measurements was investigated through between-institution heterogeneity, the true effect was not further explored with sensitivity analyses nor adjusted for in the final analysis. The difference between tumor thickness and DOI is important, as demonstrated by Arora et al. 32 who investigated both the effect of tumor thickness and DOI. Whereas DOI was an independent predictor regional metastasis, tumor thickness was not. They found that a 4-mm cutoff point was optimal for the detection of lymph node metastasis, but this included all oral cavity subsites and not all 336 patients underwent elective neck dissection. Additionally, because this study population was based in India, most tumors were from the buccal mucosa and the majority (62%) of individuals had a history of betel nut use. Thus, differences in findings may also represent different etiologic and anatomic factors of the disease. The importance of DOI is important not only for prognostication but also for decisions about elective neck dissection in early oral cavity cancer. The NCCN Head and Neck Cancer guidelines suggest consideration of elective neck dissection when DOI is greater than 4 mm.
2 D'Cruz et al. 33 performed a randomized control trial and demonstrated improved prognosis with elective compared to therapeutic neck dissection. Although DOI was not a focus of this article, subgroup analysis demonstrated a statistically significantly increased nodal positivity when tumor depth increased from 3 to 4 mm, suggesting a 3-mm threshold for elective neck dissection. However, the method of tumor depth measurement was not well defined, the cut-point was not maximized to sensitivity and specificity, and analysis was not stratified according to different oral cavity subsites. In our study, optimal cut-points of 7 and 8 mm both yield an occult nodal rate of less than 20%, the usual decision point for elective treatment of the neck. 34 However, under current treatment pathways, survival following diagnosis of early oral cavity cancer is favorable, and survival following recurrent disease is poor. 35, 36 Thus, risks of occult disease should be weighed against risks of neck dissection on a per-patient and per-surgeon basis according to their risk tolerance. Changing current treatment practices should be done with care, only after further prospective studies or studies corroborating these findings in other practice settings.
Interpretation of these results of our study needs to be considered in concert with its limitations. Firstly, this study is a retrospective cohort study, thus adjuvant treatment was decided based on patient and pathological characteristics, rather than assigned randomly. We attempted to control for these factors using stratified and multivariate analyses. Secondly, patients who did not undergo elective neck dissection were not included in this study. Forty-five patients excluded due to this reason had thinner lesions, but the lack of neck dissection precludes measurement of occult nodal disease, our primary outcome measure, and thus inclusion in our analysis. This exclusion may bias our calculated optimal DOI cut-points. Sentinel lymph node biopsy may allow for further exploration of this limitation. Currently, sentinel lymph node biopsy has been applied to oral cavity lesions of all thicknesses, and occult nodal disease may be identified in patients with thinner tumors without the morbidity of a formal neck dissection. 37 Thirdly, the rate of locoregional recurrence was low in our study cohort, limiting the ability to investigate this end point. As recurrence is a major determinant of prognosis in oral cavity cancer, a future larger cohort of patients may allow for further investigation of this important outcome measure. Despite these limitations, this study is a large cohort study involving a homogenous patient population, investigating DOI in lateral OTSCC as a continuous variable. Great effort has been made to ensure that measurement of DOI, the major risk factor of interest, has been done in a standardized manner by re-review of all pathologic specimen using 1 head and neck pathologist. Although we found that optimal cut-points to be 7 mm for detection of occult disease and 8 mm for OS and DSS differing from previous studies, studies focusing on oral tongue lesions also found a wide variety of cut-points. In addition, these studies often measured tumor thickness, rather than DOI, which may overestimate the risk in exophytic lesions and underestimate the risk in ulcerative lesions. Lastly, many studies relied on using cut-points determined a priori based on historical literature, rather than cut-points determined de novo based on study findings, meaning that the reported optimal cut-points may reflect historical precedence, rather than true differences in prognostication.
| CONCLUSION
This large homogenous cohort of patients with lateral OTSCC demonstrated an optimal cut-point for detection of occult nodal metastasis was 7.25 mm. An 8-mm cut-point best prognosticated OS and DSS at 5 years. As demonstrated in previous literature, DOI is an independent predictor of OS and DSS. However, after multivariate adjustment, DOI was not independently associated with nodal metastasis. Although the 8-mm and 7-mm cut-points demonstrate a rate of occult nodal metastasis of <20%, changes in practice should not be undertaken prior to prospective or corroborating evidence. Future studies should focus on standardization of DOI measurement technique and understanding differences in the effect of DOI in different oral cavity subsites on patient outcomes.
